Guillain-Barre Syndrome (GBS)-Market Insights, Epidemiology and Market Forecast-2023
[Report Updated: 30-05-2017]

Published by Delve Insight: 30 May 2017 | 84346

Sorry, this report is no longer available.

We may have other suitable reports available - try Searching for Guillain-Barre
or contact our sales team for personal assistance: phone +44 (0)7887945155 or email pdb@bioportfolio.co.uk.

Introduction

Note*: This report requires 5-7 business days to complete.

DelveInsight’s Guillain-Barre Syndrome (GBS) - Market Insights, Epidemiology and Market Forecast-2023” Reports provides an overview of the disease and global market trends of the Guillain-Barre Syndrome (GBS) for the seven major markets ie: United States, EU5 (France, Germany, Italy, Spain, UK) and Japan. The Report covers the therapeutics market revenue; average cost of therapy, treatment practice and Guillain-Barre Syndrome (GBS) forecasted market share for ten years to 2023 segmented by seven major markets. In addition, the report also includes global forecast of epidemiology of Guillain-Barre Syndrome (GBS) till 2023.

Key Coverage and Benefits

• The report will help in developing business strategies by understanding the trends shaping and driving the global Guillain-Barre Syndrome (GBS) market.

• Identifying patient populations in the global “Guillain-Barre Syndrome (GBS) market to improve product design, pricing, and launch plans.

• Organize sales and marketing efforts by identifying the best opportunities for Guillain-Barre Syndrome (GBS) therapeutics in each of the markets covered.

• To understand the future market competition in the global Guillain-Barre Syndrome (GBS) therapeutics market and Insightful review of the key market drivers and barriers.

Scope

• Report covers the disease overview including etiology, path physiology, symptoms, diagnosis, disease management, and current treatment options.

• Marketed information including available prescription drugs, its patent and exclusivity details followed by drug sales till 2018.

• The Report also covers the detailed global historical and forecasted epidemiological data covering United States, EU5, Japan and rest of the word from 2013-2023.

• It also provides Guillain-Barre Syndrome (GBS) for United States, EU5 and Japan from 2013 and forecasted Market to 2023.

Table of Contents
for Guillain-Barre Syndrome (GBS)-Market Insights, Epidemiology and Market Forecast-2023 [Report Updated: 30-05-2017]

List Of Tables
in Guillain-Barre Syndrome (GBS)-Market Insights, Epidemiology and Market Forecast-2023 [Report Updated: 30-05-2017]

• Table 1: Drug Description

• Table 2: Drug, Marketed Details United States (US)

• Table 3: Drug, Patent Number Specific Patent Expiry in US (Year), 2015

• Table 4: Drug, Patent Details for US

• Table 5: Guillain Drug Sales (USD Millions)

• Table 6: Global Epidemiology of Guillain(2013-2023)

• Table 7: Guillain Global Market (USD Millions), (2013-2015)

• Table 8: Guillain Global Market (USD Millions), (2016-2023)

• Table 9: Guillain US Market (USD Millions), (2013-2015)

• Table 10: Guillain US Market (USD Millions), (2016-2023)

• Table 11: Guillain Germany Market (USD Millions), (2013-2015)

• Table 12: Guillain Germany Market (USD Millions), (2016-2023)

• Table 13: Guillain United Kingdom Market (USD Millions), (2013-2015)

• Table 14: Guillain United Kingdom Market (USD Millions), (2016-2023)

• Table 15: Guillain France Market (USD Millions), (2013-2015)

• Table 16: Guillain France Market (USD Millions), (2016-2023)

• Table 17: Guillain Italy Market (USD Millions), (2013-2015)

• Table 18: Guillain Italy Market (USD Millions), (2016-2023)

• Table 19: Guillain Spain Market (USD Millions), (2013-2015)

• Table 20: Guillain Spain Market (USD Millions), (2016-2023)

• Table 21: Guillain Japan Market (USD Millions), (2013-2015)

• Table 22: Guillain Japan Market (USD Millions), (2016-2023)

• Table 23: Guillain ROW Market (USD Millions), (2013-2015)

• Table 24: Guillain ROW Market (USD Millions), (2016-2023)

List Of Figures, Charts and Diagrams
in Guillain-Barre Syndrome (GBS)-Market Insights, Epidemiology and Market Forecast-2023 [Report Updated: 30-05-2017]

• Figure 1: Guillain Drug Sales (USD Millions)

• Figure 2: Global Epidemiology of Guillain(2013-2023)

• Figure 3: Guillain Global Market (USD Millions), (2013-2015)

• Figure 4: Guillain Global Market (USD Millions), (2016-2023)

• Figure 5: Guillain US Market (USD Millions), (2013-2015)

• Figure 6: Guillain US Market (USD Millions), (2016-2023)

• Figure 7: Guillain Germany Market (USD Millions), (2013-2015)

• Figure 8: Guillain Germany Market (USD Millions), (2016-2023)

• Figure 9: Guillain United Kingdom Market (USD Millions), (2013-2015)

• Figure 10: Guillain United Kingdom Market (USD Millions), (2016-2023)

• Figure 11: Guillain France Market (USD Millions), (2013-2015)

• Figure 12: Guillain France Market (USD Millions), (2016-2023)

• Figure 13: Guillain Italy Market (USD Millions), (2013-2015)

• Figure 14: Guillain Italy Market (USD Millions), (2016-2023)

• Figure 15: Guillain Spain Market (USD Millions), (2013-2015)

• Figure 16: Guillain Spain Market (USD Millions), (2016-2023)

• Figure 17: Guillain Japan Market (USD Millions), (2013-2015)

• Figure 18: Guillain Japan Market (USD Millions), (2015-2023)

• Figure 19: Guillain ROW Market (USD Millions), (2013-2015)

• Figure 20: Guillain ROW Market (USD Millions), (2016-2023)

Additional Details

Publisher

Delve Insight

Publisher Information

DelveInsight is a leading Business Consulting and Market Research Firm. We combine industry expertise with probing market insights in innovative ways to deliver enduring results to deliver critical information to leading decision makers.



We help our clients to find answers relevant to their business, facilitating decision-making; identify potential market opportunities, competitor assessments and business environmental assessment. DelveInsight is a knowledge partner for business strategy and market research across the drug value chain.

Reference

84346 | DIMFR2017072

Number of Pages

70

Report Format

PDF

Delve Insight Reports

Related Reports

TitleDate PublishedPrice fromMore Details
Guillain-Barre Syndrome Global Clinical Trials Review, H2, 2017
Guillain-Barre Syndrome Global Clinical Trials Review, H2, 2017SummaryGlobalData's clinical trial re...
30 Aug 2017 by Global Data USD $2,500 More Info
Guillain-Barre Syndrome - Pipeline Insight, 2017
DelveInsight’s, “Guillain-Barre Syndrome-Pipeline Insights, 2017”, report provides comprehensive ins...
31 Jul 2017 by Delve Insight USD $1,250 More Info
Guillain-Barre Syndrome - Pipeline Insight, 2017
DelveInsight’s, “Guillain-Barre Syndrome-Pipeline Insights, 2017”, report provides comprehensive ins...
31 Jul 2017 by Delve Insight USD $1,250 More Info
Guillain - Epidemiology Forecast To 2023
DelveInsight “Guillain - Epidemiology Forecast To 2023” provides an overview of the epidemiology tre...
31 May 2017 by Delve Insight USD $2,750 More Info
Guillain-Barre Syndrome-Pipeline Insights, 2017
DelveInsight’s, “ Guillain-Barre Syndrome-Pipeline Insights, 2017”, report provides in depth insight...
30 May 2017 by Delve Insight USD $1,250 More Info
Malaysia Intravenous Immunoglobulin (IVIG) Market by Product Types (IgG, IgA, IgM, IgE and IgD), Application (Hypogammaglobulinemia, Chronic Inflammatory Demyelinating Polyneuropathy, Immunodeficiency Diseases, Myasthenia Gravis, Multifocal Motor Neuropathy, Primary Immune Thrombocytopenic Purpura, Inflammatory Myopathies, Specific Antibody Deficiency, Guillain-Barré Syndrome, Kawasaki Disease,
CHAPTER 1 INTRODUCTION1.1. REPORT DESCRIPTION1.2. KEY BENEFITS FOR STAKEHOLDERS1.3. KEY MARKET SEGME...
24 May 2017 by Allied Market Research USD $2,850 More Info
Guillain-Barre Syndrome - Pipeline Review, H1 2017
Guillain-Barre Syndrome - Pipeline Review, H1 2017SummaryGlobal Markets Direct's latest Pharmaceutic...
09 May 2017 by Global Markets Direct USD $2,000 More Info
Guillain-Barre Syndrome Global Clinical Trials Review, H2, 2016
Guillain-Barre Syndrome Global Clinical Trials Review, H2, 2016SummaryGlobalData's clinical trial re...
21 Sep 2016 by Global Data USD $2,500 More Info
Guillain-Barre Syndrome Global Clinical Trials Review, H1, 2016
Guillain-Barre Syndrome Global Clinical Trials Review, H1, 2016SummaryGlobalData's clinical trial re...
30 Jun 2016 by Global Data USD $2,500 More Info
IVIG Market: By Application (Hypogammaglobulinemia, CIDP, Immunodeficiency diseases, Congenital AIDS, Chronic Lymphocytic Leukemia, Myasthenia Gravis, Multifocal Motor Neuropathy, ITP, Kawasaki Disease, Guillain-Barre Syndrome), By Route of Administration (Intravenous, Subcutaneous), By Geography-Forecast (2016-2021)
Immunoglobulin refers to the breakdown of blood plasma that contains antibody and Intravenous immuno...
26 Feb 2016 by USD $5,250 More Info

This report is published by Delve Insight

DelveInsight is a leading Business Consulting and Market Research Firm. We combine industry expertise with probing market insights in innovative ways to deliver enduring results to deliver critical information to leading decision makers.

We help our clients to find answers relevant to their business, facilitating decision-making; identify potential market opportunities, competitor assessments and business environmental assessment. DelveInsight is a knowledge partner for business strategy and market research across the drug value chain.

We Stock...